Home > Boards > US Listed > Medical - Equipment > Obalon Therapeutics, Inc. (OBLN)

$3.08

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
r clarke Member Profile
 
Followed By 11
Posts 2,756
Boards Moderated 1
Alias Born 11/16/13
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/13/2019 4:08:23 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/13/2019 4:03:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 12:28:00 PM
Obalon Appoints Bob MacDonald as Chief Retail Officer GlobeNewswire Inc. - 6/10/2019 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/7/2019 5:05:43 PM
Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System GlobeNewswire Inc. - 6/4/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 7:16:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/3/2019 7:16:05 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/31/2019 5:31:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2019 5:12:26 PM
Under the Radar Biotechs To Research Now InvestorsHub NewsWire - 5/30/2019 1:40:00 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/30/2019 6:09:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/30/2019 6:05:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2019 5:23:42 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/28/2019 6:05:25 AM
Obalon Therapeutics, Inc. Prices $3,000,000 Registered Direct Offering GlobeNewswire Inc. - 5/23/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2019 4:52:11 PM
Expanded Clinical Data Set for the Obalon Balloon System Presented at DDW 2019 GlobeNewswire Inc. - 5/21/2019 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2019 4:03:47 PM
Obalon Announces Receipt of Delisting Notification Letters from Nasdaq GlobeNewswire Inc. - 5/17/2019 4:01:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 5:24:07 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2019 6:28:44 AM
Obalon Engages Cowen to Explore Financial and Strategic Alternatives GlobeNewswire Inc. - 4/11/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/3/2019 8:32:38 AM
Obalon Announces Restructuring to Streamline Operations & Cash Use GlobeNewswire Inc. - 4/3/2019 8:30:00 AM
r clarke   Friday, 09/07/18 03:46:02 PM
Re: None
Post # of 345 
$3.08


Obalon to Host Corporate Strategy Update Call with Investors and Analysts on September 10, 2018

GlobeNewswire•August 29, 2018

SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it plans to host a Corporate Strategy Update conference call and simultaneous webcast on September 10, 2018 at 10am Eastern Time (7am Pacific Time). The call is intended to provide investors and analysts with lessons learned during the first 18 months of US commercialization of the Obalon Balloon System, management’s revised strategy based on those learnings, and metrics upon which effectiveness of the revised strategy will be measured.

Interested parties may access the conference call by dialing (844) 889-7791 (U.S.) or (661) 378-9934 (international) using passcode 8597517. Media and individuals will be in a listen-only mode. Participants are asked to dial in a few minutes prior to the call to register for the event. The conference call will also be webcast live at: https://edge.media-server.com/m6/p/azz9fe99.

An archive of the webcast will be available for twelve months following the event on the Obalon Therapeutics website located at http://investor.obalon.com in the “News & Events” section.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist